Stephen Thompson
PR firm for Ontario's Ministry of Economic Development, Trade & Employment/Ministry of Research and Innovation

DOI:https://doi.org/10.5912/jcb660


Abstract:

Transforming medical research findings into viable commercial enterprises is a persistent challenge. Ontario, Canada, has deployed several approaches that could be applied in other regions. The provincial government has created R&D tax incentives, investment funds and commercialization incubators, along with streamlining clinical trials regulatory processes, to increase speed-to-market for medical biotechnology innovations. By creating supportive government policies, providing seed capital, and promoting partnerships between research institutions and industry, Ontario helps start-ups such as ApneaDX and OtoSim attract follow-on funding and access markets.


Keywords:collaboration ,tax incentives ,public-private ,Ontario ,MaRS ,clinical trial ,Ontario ,Canada's Ministry of Economic Development ,Trade and Employment ,Ministry of Research and Development ,en ,